ONCY ▲ +4.3% - Oncolytics Biotech Inc. $ONCY - Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers 27-OCT-2026 09:30 AM ET